The Xa factor: not looking so promising for Pfizer and Bristol - Bristol-Myers Squibb and Pfizer's apixaban blood clot preventer raised rates of bleeding in a 6-month study but showed some encouraging …
Pharma News 3_1
Wyeth gets Pristiq approved (a derivative of Effexor) for Major Depressive Disorder. Speaking of anti-depressants, lots of noise being made - and arguments back and forth - about whether they are …
Celgene makes a move; Schering flips the birds to Wyeth
Looks, on the surface, like a good match of products and market presence - Celgene buys Pharmion. And, in other important oncology news, Nexavar (from Bayer) gets expedited approval for liver …
Continue Reading about Celgene makes a move; Schering flips the birds to Wyeth →